OBJECTIVE Gonadotropin-releasing hormone analogs revolutionized the treatment of central precocious puberty. However, questions remain regarding their optimal use in central precocious puberty and other conditions. The Lawson Wilkins Pediatric Endocrine Society and the European Society for Pediatric Endocrinology convened a consensus conference to review the clinical use of gonadotropin-releasi...

until 2000 it was believed that gonadotropin-releasing hormone (gnrh) was the sole regulator of hypophyseal gonadotropes. in 2000, the discovery of a gonadotropin inhibitory hormone (gnih) initiated a revolution in the field of reproductive physiology. identification of gnih homologues in mammals, the arginine-phenylalanine- amide (rfamide)-related peptides (rfrps), indicated a similar function...

A gonadotropin-releasing peptide has been isolated from human follicular fluid. Its amino acid composition and sequence are completely different from the hypothalamic lutropin-releasing hormone. It is designated human follicular gonadotropin-releasing peptide and abbreviated as hF-GRP. The primary structure of this peptide (H-Thr-Asp-Thr-Ser-His-His-Asp-Gln-Asp-His-Pro-Thr-Phe-Asn-OH) has been ...

Efficacy of poly (lactic-co-glycolic acid) microparticles as a gonadotropin-releasing hormone analogue delivery system to stimulate ovulation peled Coregonus | Jindriška Knowles, Jakub Vysloužil, Jan Muselík, Vlastimil Stejskal, Kouřil, Peter Podhorec Agricultural Journals

Summary Statements1.The particular follicle-stimulating hormone formulation used for ovarian stimulation does not affect the incidence of hyperstimulation syndrome. (I)2.Coasting may reduce severe (III)3.Coasting longer than 3 days reduces in vitro fertilization pregnancy rates. (II-2)4.The use either luteinizing or human chorionic gonadotropin final oocyte maturation influence (I)5.There is no...

OBJECTIVE: The aim of this study is to evaluate the outcomes gonadotropin-releasing hormone agonist treatment for ovarian cysts, which are developed during tamoxifen use due breast cancer. STUDY DESIGN: This was a retrospective cohort including patients who were under stage I-III cancer and administered leuprolide acetate cysts with low malignancy risk between 2012-2020. RESULTS: Leuprolide tot...